Fetuin-A and sodium concentrations are independently associated with all-cause mortality in patients awaiting heart transplantation

Abstract

has increased significantly. 3 Cardiac biomarkers are used as a minimally invasive way to assess the condition of patients with HF. They facilitate the initial diagnosis and prognostic stratification and they play an important role in the identification of a patient's possible response to a therapeutic intervention. 2-5 However, with the exception of natriuretic peptides and troponins, the reliability INTRODUCTION End -stage heart failure (HF) is a clinical condition with a complex pathophysiology and poor prognosis. A variety of pathophysiological processes involved in the development and progression of the disease-such as fibrosis, inflammation, myocardial injury, and remodeling-can be monitored with biomarkers. 1,2 Over the past few years, the role of biomarkers in HF

Ceruloplasmin, Catalase and Creatinine Concentrations Are Independently Associated with All-Cause Mortality in Patients with Advanced Heart Failure

“…During RHC, 10 mL of blood from the coronary sinus was collected from all patients. The protocol for blood collection from the coronary sinus was described in the study by Szczurek-Wasilewicz et al [ 9 ].…”

The serum concentration of brain-derived neurotrophic factor is lower in ambulatory and clinically stable patients with more advanced systolic heart failure

“…A serach for new indicators of different aspects of heart failure continues. For example, Szczurek-Wasilewicz et al report that lower fetuin-A levels are associated with an increased risk of death from end-stage heart faulire [4].…”